Research and Innovation Cores Logo

Research and Innovation Cores Office (RIC)

Get Started

About Us

The Research and Innovation Cores Office enables the provision of research support services to clients worldwide. As a business hub, our office manages commercial transactions associated with services provided by UHN Research & Innovation Cores.

Our Services

The Research and Innovation Cores Office serves as the business operations hub between UHN Research teams and clients. Our services include:

  • checkmarkClient needs assessments and Consultations
  • checkmarkProcessing of Service Agreements and Non-Disclosure Agreements
  • checkmarkInvoicing and Account Receivables Functions
  • checkmarkBusiness Development; and
  • checkmarkCentralized Core Equipment Management

The Research & Innovation Cores Team

Jose Mangles

Director of Operations

Cameron Orovan


Ida Bejelia

Financial Analyst II

Beatrice Louis

Marketing & Brand Analyst

Fahim Medhizadah

Business Analyst

Dragan Gligorov

Business Development Specialist

Anand Mathews

Business Analyst

Krishna Bhatt

Financial Analyst II


The team can be contacted by sending an email to

Scheduling an initial consultation to tell us about the needs of your research study will enable us to evaluate and recommend which services at UHN would most suit your needs. Please email us at

Yes, we do. Our centralized model enables the utilization of specialized equipment and facilities to a variety of clients worldwide, including industry, academia, and research institutes as well as to healthcare organizations.

Depending upon the specific needs of your research study, prices may vary. It is not possible to anticipate costs unless a proper assessment is conducted by our specialized technical staff.

Our processes and business practices are fully aligned with existing legislation and regulations and corporate policies governing the protection of intellectual property associated with your studies.

Yes. There are certain mandatory requirements that need to be met by users/clients prior to utilize our equipment.

Yes. Our research teams have demonstrated expertise in managing large and small Phase I, II and III oncology clinical trials and drug development.